Abstract: This invention relates to Pulsatillae Radix extract for improving brain functions. More specifically, this invention relates to Pulsatillae Radix extract, its active fractions and a pharmaceutical product and a health food containing the same respectively having a protective activity against neurotoxicity and a growth inhibitory effect induced by beta-amyloid, an anti-oxidizing effect, a neuron proliferating effect and improving memory thereby effective in improving brain functions such as Mild Cognitive Impairment and dementia.

Abstract: A seat light and plaque holder including a seat light base having a downwardly angled mounting surface and an upwardly angled mounting surface with a first plurality of LEDs mounted on the downwardly angled mounting surface and a second plurality of LEDs is mounted on the upwardly angled mounting surface. A light cover is attached to the seat light base having a row marker positioned thereon to be backlit by the second plurality of LEDs and an end portion of a length selected to shield the downwardly angled first plurality of LEDs from view of persons walking up or down an aisleway while directing illumination towards an aisleway.

Abstract: The present invention relates to the use of oleanane-type triterpene saponin compounds, which are effective for improving memory and learning ability, as an effective ingredient of drugs for the treatment and prevention of dementia and mild cognitive impairment and health foods for the improvement of brain functions including cognitive function.

Abstract: Liquid electro-photographic (LEP) printers having a coating disposed thereon, LEP printers having a compound such as fluorosurfactant in the resin to make one or more parts of the LEP printer, and the like, are disclosed.

Abstract: The present invention relates to the triterpene compounds improving in brain functions. In particular, the present invention relates to a novel use of the triterpene compounds represented by the Formula 1 for improving decreased memory and a pharmaceutical composition for improving brain functions comprising the triterpene compounds represented by the Formula 1.

Abstract: The present invention relates to uses of Macrolactin A produced by Bacillus polyfermenticus KJS-2 (KCCM 10769P), which is a new bacillus strain, as an antibiotic. Macrolactin A of the present invention, which is produced by Bacillus polyfermenticus KJS-2, shows a broad spectrum of antibiotic activity against a variety of microorganisms and fungi, and is proved to be very efficient for the inhibition of particularly vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus Aureus (MRSA) that are multidrug-resistant bacteria. The antibiotic Macrolactin A produced by Bacillus polyfermenticus KJS-2, can be used as an excellent antibiotic against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus Aureus (MRSA), and thus the present invention is a very useful invention for medical industry.

Abstract: A method for displaying image is provided. The method includes: selecting an image file; reading property values of the selected image file, and displaying the property values of the selected image file on the display; selecting one of the property values in response to a select operation via the input unit, and storing the selected property value as selected image property value; searching the property value of the image files in the memory that match the selected image property value; displaying the found image files.

Abstract: A method for classifying image is provided. The method includes: selecting an image; extracting parameters of the selected image and displaying the extracted parameter in a reminder menu; selecting a extracted parameter; defining the selected parameter as the image classifying standard; creating an image classification folder named with the image classifying standard; retrieving images according to the image classifying standard; and storing the images that were retrieved into the created folder.

Abstract: A method for updating pictures asynchronously is provided. The method comprises: extracting parameter values of a selected picture; defining extracted parameter values as standard parameter values; and adjusting parameter values of other pictures according to the standard parameter values.

Abstract: A method for displaying image is provided. The method includes: providing at least one image display mode, the image display mode defines a total number of images displayed on a display, a size of each of display areas, and an duration of displaying image on the biggest possible display area; obtaining images and the image display mode; configuring one or more display areas according to the image display mode; and displaying images on the biggest possible display area in a special order according to the duration.

Abstract: A method of searching media file applied on a DPF which includes: a memory, an input unit, a reading module, a determining module; and a displaying module. The method includes: obtaining the search table from the memory via the reading module, wherein the search table records relationships between the duration and a search manner; receiving an operation information of the input unit; determining a search manner according to the duration and the search table via the determining module; searching media files according to the determined search manner via the displaying module.

Abstract: Disclosed are agents that inhibit histone deacetylase. More specifically, the present invention relates to novel hydroxamic acid derivatives or pharmaceutically acceptable salts thereof for anticancer agents or other therapeutic agents based on their histone deacetylase inhibitory activity.

Abstract: This invention relates to Pulsatillae Radix extract for improving brain functions. More specifically, this invention relates to Pulsatillae Radix extract, its active fractions and a pharmaceutical product and a health food containing the same respectively having a protective activity against neurotoxicity and a growth inhibitory effect induced by beta-amyloid, an anti-oxidizing effect, a neuron proliferating effect and improving memory thereby effective in improving brain functions such as Mild Cognitive Impairment and dementia.

Abstract: The present invention relates to novel quinazoline derivatives effective in lowering blood glucose level and body weight, and a medicine for treatment and/or prevention of diabetes and/or obesity, which comprises the compound as an active ingredient.

Abstract: The present invention relates to the triterpene compounds improving in brain functions. In particular, the present invention relates to a novel use of the triterpene compounds represented by the Formula 1 for improving decreased memory and a pharmaceutical composition for improving brain functions comprising the triterpene compounds represented by the Formula 1.

Abstract: A battery cover latching assembly (30) is used in a portable electronic device (9). The portable electronic device has a housing (10) and a battery cover (20) releasably connected via the battery cover latching assembly. The housing has a button hole (171) defined in one end portion thereof. The battery cover latching assembly has a button (40) and a spring (50). The button and the spring are installed in the button hole of the housing. The button is movable relative to the housing for assembling or disassembling the battery cover to or from the housing.

Abstract: The invention relates to a series of pyrrolopyrimidinone derivatives of the formula (1): wherein R1 is H; C1-C3 alkyl optionally substituted with one or more fluoro atoms; or C3-C6 cycloalkyl; R2 is H; a halogen atom; C1-C6 alkyl optionally substituted with OH, C1-C3 alkoxy, C3-C6 cycloalkyl, or with one or more fluoro atoms; C3-C6 cycloalkyl; C2-C6 alkenyl; or C2-C6 alkynyl; R3 is H; C1-C6 alkyl optionally substituted with OH, C1-C3 alkoxy, C3-C6 cycloalkyl, or with one or more fluoro atoms; C3-C6 cycloalkyl; C2-C6 alkenyl; or C2-C6 alkynyl; R4 is C1-C6 alkyl optionally substituted with C3-C6 cycloalkyl or with one or more fluoro atoms; C2-C6 alkenyl; C2-C6 alkynyl; or C3-C6 cycloalkyl; and R5 is SO2NR6R7; NHSO2NR6R7; NHCOCONR6R7; NHSO2R8; NHCOR8; or phenyl or heterocyclyl either of which is optionally substituted with one or more fluoro atoms or C1-C3 alkyl.

Abstract: The invention relates to a series of pyrrolopyrimidinone derivatives, processes for their preparation, intermediates in their preparation, their use as therapeutic agents, and pharmaceutical compositions containing them.

Abstract: Disclosed are agents that inhibit histone deacetylase. More specifically, the present invention relates to novel hydroxamic acid derivatives or pharmaceutically acceptable salts thereof for anticancer agents or other therapeutic agents based on their histone deacetylase inhibitory activity.